http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0765865-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd569fbfa1953ca9b7b375510e4d2763
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-798
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S977-904
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-22
filingDate 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a115bc4203bca810668d28c1282c26b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1206061fb9aebaceced1bd640759bde8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86042162fb4f8fd8c1a29d388042cecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_816716319269297fd320478ec4ca99c7
publicationDate 1997-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0765865-A4
titleOfInvention 2-ACYLAMINOPROPANOL COMPOUND AND MEDICINAL COMPOSITION
abstract A 2-acylaminopropanol compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, and a medicinal composition containing the same as the active ingredient and being efficacious as an antiviral agent and a remedy for nervous diseases, wherein R1 represents phenyl which may be substituted by one to three same or different substituents selected from among alkyl, alkoxy, hydroxy, hydroxyalkyl and nitro; R2 represents a group represented by any of general formulae (II) through (VI) wherein, R?3, R4, R5, R6, R7, R8, R9¿, m and p are each as defined in the specification; R11 represents hydrogen or hydroxy; and n represents an integer of 3 to 15.
priorityDate 1994-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9427607-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9710817-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226640228
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43499492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 39.